About

Nozer Mehta, PhD, Principal, Peptide Technologies, received Bachelors and Masters degrees from the University of Bombay, India, and a Doctorat d’Université with Honours from the Université Louis Pasteur in France. His early work experience was at the CNRS laboratories in Strasbourg, at the Cancer Research Institute in Mumbai and at the University of Nebraska in Lincoln. He joined Unigene Laboratories in 1982 and advanced to Chief Scientific Officer and served next, also as CSO, at Enteris BioPharma. At both companies he and his team developed programs and technologies for oral delivery and recombinant expression of peptides. He then worked at MonoSol Rx as the Vice-President for Biologics, where he led research efforts on the buccal delivery of peptides. Dr Mehta currently consults for pharmaceutical companies and venture capital groups.

Contributions

EXPERT VIEW

TECHNOLOGIES & CLINICAL STUDIES FOR THE ORAL DELIVERY OF CALCITONIN

Nozer Mehta, James P Gilligan and William Stern summarise the different technologies that have been in development for oral delivery of peptides through the gastro-intestinal mucosal surfaces via the transcellular or the paracellular pathways and describe the results of several long-term clinical studies on the oral delivery of salmon calcitonin.